Articles From: SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Retrophin, Inc. to Contact Brower Piven Before the December 19, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- RTRX to SHAREHOLDER ALERT: Class Action Lawsuit Against Alcobra, Ltd. Filed By Glancy Binkow & Goldberg LLP


Save the Children named as Enterprise Wide Global Partner NEW BRUNSWICK, N.J. , Nov.
Sign-up for Johnson & Johnson Partners with Save the Children to Help Millions of Children over the Next Three Years investment picks
Two Pacific Northwest Community-Focused Business Banks Agree to Merge in a Strategic Combination EUGENE, Ore.
Sign-up for Pacific Continental Corporation Announces Acquisition Of Capital Pacific Bancorp investment picks
NEW YORK , Nov.
Sign-up for Harwood Feffer LLP Announces Investigation of Oplink Communications, Inc. investment picks
PLEASANTON, Calif., Nov.
Sign-up for Adept Technology Hires Vice President for North America investment picks
CHATTANOOGA, Tenn., Nov.
Sign-up for Covenant Transportation Group Upsizes and Prices Public Offering of Class A Common Stock investment picks
COPPELL, Texas, Nov.
Sign-up for ZS Pharma Hosts and Webcasts Investor Event investment picks
FALLS CHURCH, Va.
Sign-up for Northrop Grumman Board Declares Quarterly Dividend investment picks
Foundation Medicine, Inc. (NASDAQ: FMI) today announced the presentation of new data from its ongoing collaboration with Clovis Oncology (NASDAQ: CLVS) to develop a novel companion diagnostic test to identify patients who have the potential to benefit from rucaparib, Clovis Oncology's poly (ADP-ribose) polymerase inhibitor (PARPi). These new data suggest that Foundation Medicine’s novel companion diagnostic can identify both BRCA-mutant patients and non BRCA-mutant patients who are more likely to benefit from rucaparib than patients who are biomarker negative.
Sign-up for Foundation Medicine’s Novel Companion Diagnostic Test, Developed in Collaboration with Clovis Oncology, Identifies Expanded Subgroup of Cancer Patients with the Potential to Respond to Clovis Oncology’s PARP inhibitor, Rucaparib investment picks
SJW Corp.
Sign-up for SJW Corp. to Present at the 18th Annual Water Conference investment picks
M/A-COM Technology Solutions Inc. ( MACOM ), a leading supplier of semiconductor solutions for broadcast video infrastructure, announced today that its award-winning 12G-SDI Chipset supports transmission of 4k60p video utilizing a single 12Gbps link over 80 meters of L-4.5CHD coaxial cable.
Sign-up for MACOM’s 12G-SDI Chipset Adopted by Canare to Support the Transmission of 4K Video over a Single Link at 12Gbps investment picks
Operating Loss Reduced 41% With Cash Preservation Steps Undertaken PHILADELPHIA , Nov.
Sign-up for Echo Therapeutics Announces Third Quarter 2014 Financial Results investment picks
DUBLIN, Calif.
Sign-up for Ross Stores Announces Quarterly Dividend investment picks
TORONTO , Nov.
Sign-up for Pacific Rubiales announces update on its normal courese issuer bid investment picks
THE WOODLANDS , Texas, Nov.
Sign-up for Huntsman To Present At Upcoming Conferences investment picks
HOUSTON , Nov.
Sign-up for Boardwalk Prices $350 Million Offering Of Senior Notes investment picks
Yahoo (YHOO) said it would become the default search engine on Mozilla Corp.'s Firefox browser in the U.S. on mobile and desktop devices.
Sign-up for Yahoo to be default search engine for Firefox investment picks
CARMICHAELS, Pa., Nov.
Sign-up for CB Financial Services, Inc. Announces Quarterly Cash Dividend investment picks
Shares of Caesars Entertainment Corp.
Sign-up for Caesars shares rally on reported REIT plan investment picks
Glancy Binkow & Goldberg LLP , representing investors of Alcobra, Ltd.
Sign-up for SHAREHOLDER ALERT: Class Action Lawsuit Against Alcobra, Ltd. Filed By Glancy Binkow & Goldberg LLP investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Retrophin, Inc. to Contact Brower Piven Before the December 19, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- RTRX to SHAREHOLDER ALERT: Class Action Lawsuit Against Alcobra, Ltd. Filed By Glancy Binkow & Goldberg LLP
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent